|
1
|
Devesa SS, Blot WJ and Fraumeni JF Jr:
Changing patterns in the incidence of esophageal and gastric
carcinoma in the United States. Cancer. 83:2049–2053. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siewert JR and Stein HJ: Classification of
adenocarcinoma of the oesophagogastric junction. Br J Surg.
85:1457–1459. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sobin LH, Gospodarowicz MK and Wittekind
C: International union against cancer: TNM classification of
malignant tumours. Wiley-Blackwell. Chichester, West Sussex, UK:
2010.
|
|
4
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schiesser M and Schneider PM: Surgical
strategies for adenocarcinoma of the esophagogastric junction.
Recent Results Cancer Res. 182:93–106. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Esposito I, Konukiewitz B, Schlitter AM
and Klöppel G: Pathology of pancreatic ductal adenocarcinoma:
Facts, challenges and future developments. World J Gastroenterol.
20:13833–13841. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hidalgo M: Pancreatic cancer. N Engl J
Med. 362:1605–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Raimondi S, Maisonneuve P and Lowenfels
AB: Epidemiology of pancreatic cancer: An overview. Nat Rev
Gastroenterol Hepatol. 6:699–708. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arvold ND, Ryan DP, Niemierko A,
Blaszkowsky LS, Kwak EL, Wo JY, Allen JN, Clark JW, Wadlow RC, Zhu
AX, et al: Long-term outcomes of neoadjuvant chemotherapy before
chemoradiation for locally advanced pancreatic cancer. Cancer.
118:3026–3035. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cristofanilli M, Budd GT, Ellis MJ,
Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ,
Terstappen LW and Hayes DF: Circulating tumor cells, disease
progression and survival in metastatic breast cancer. N Engl J Med.
351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hayes DF, Cristofanilli M, Budd GT, Ellis
MJ, Stopeck A, Miller MC, Matera J, Allard WJ, Doyle GV and
Terstappen LW: Circulating tumor cells at each follow-up time point
during therapy of metastatic breast cancer patients predict
progression-free and overall survival. Clin Cancer Res.
12:4218–4224. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
de Wit S, van Dalum G and Terstappen LW:
Detection of circulating tumor cells. Scientifica (Cairo).
2014:8193622014.PubMed/NCBI
|
|
14
|
Gorges TM and Pantel K: Circulating tumor
cells as therapy-related biomarkers in cancer patients. Cancer
Immunol Immunother. 62:931–939. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tu Q, Bittencourt Mde C, Cai H, Bastien C,
Lemarie-Delaunay C, Bene MC and Faure GC: Case Report: Detection
and quantification of tumor cells in peripheral blood and ascitic
fluid from a metastatic esophageal cancer patient using the
CellSearch (R) technology. F1000Res. 3:122014.PubMed/NCBI
|
|
16
|
Matsushita D, Uenosono Y, Arigami T,
Yanagita S, Nishizono Y, Hagihara T, Hirata M, Haraguchi N, Arima
H, Kijima Y, et al: Clinical significance of circulating tumor
cells in peripheral blood of patients with esophageal squamous cell
carcinoma. Ann Surg Oncol. 22:3674–3680. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kurihara T, Itoi T, Sofuni A, Itokawa F,
Tsuchiya T, Tsuji S, Ishii K, Ikeuchi N, Tsuchida A, Kasuya K, et
al: Detection of circulating tumor cells in patients with
pancreatic cancer: A preliminary result. J Hepatobiliary Pancreat
Surg. 15:189–195. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bidard FC, Huguet F, Louvet C, Mineur L,
Bouché O, Chibaudel B, Artru P, Desseigne F, Bachet JB, Mathiot C,
et al: Circulating tumor cells in locally advanced pancreatic
adenocarcinoma: The ancillary CirCe 07 study to the LAP 07 trial.
Ann Oncol. 24:2057–2061. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang L, Riethdorf S, Wu G, Wang T, Yang
K, Peng G, Liu J and Pantel K: Meta-analysis of the prognostic
value of circulating tumor cells in breast cancer. Clin Cancer Res.
18:5701–5710. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Botteri E, Sandri MT, Bagnardi V, Munzone
E, Zorzino L, Rotmensz N, Casadio C, Cassatella MC, Esposito A,
Curigliano G, et al: Modeling the relationship between circulating
tumour cells number and prognosis of metastatic breast cancer.
Breast Cancer Res Treat. 122:211–217. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sastre J, Vidaurreta M, Gómez A, Rivera F,
Massutí B, López MR, Abad A, Gallen M, Benavides M, Aranda E, et
al: Prognostic value of the combination of circulating tumor cells
plus KRAS in patients with metastatic colorectal cancer treated
with chemotherapy plus bevacizumab. Clin Colorectal Cancer.
12:280–286. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fehm T and Sauerbrei W: Information from
CTC measurements for metastatic breast cancer prognosis-we should
do more than selecting an ‘optimal cut point’. Breast Cancer Res
Treat. 122:219–220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Romiti A, Raffa S, Di Rocco R, Roberto M,
Milano A, Zullo A, Leone L, Ranieri D, Mazzetta F, Medda E, et al:
Circulating tumor cells count predicts survival in colorectal
cancer patients. J Gastrointestin Liver Dis. 23:279–284.
2014.PubMed/NCBI
|
|
24
|
Khan MS, Tsigani T, Rashid M, Rabouhans
JS, Yu D, Luong TV, Caplin M and Meyer T: Circulating tumor cells
and EpCAM expression in neuroendocrine tumors. Clin Cancer Res.
17:337–345. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bissolati M, Sandri MT, Burtulo G, Zorzino
L, Balzano G and Braga M: Portal vein-circulating tumor cells
predict liver metastases in patients with resectable pancreatic
cancer. Tumour Biol. 36:991–996. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Königsberg R, Obermayr E, Bises G, Pfeiler
G, Gneist M, Wrba F, de Santis M, Zeillinger R, Hudec M and
Dittrich C: Detection of EpCAM positive and negative circulating
tumor cells in metastatic breast cancer patients. Acta Oncol.
50:700–710. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gorges TM, Tinhofer I, Drosch M, Röse L,
Zollner TM, Krahn T and von Ahsen O: Circulating tumour cells
escape from EpCAM-based detection due to epithelial-to-mesenchymal
transition. BMC Cancer. 12:1782012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gonzalez DM and Medici D: Signaling
mechanisms of the epithelial-mesenchymal transition. Sci Signal.
7:re82014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vona G, Sabile A, Louha M, Sitruk V,
Romana S, Schütze K, Capron F, Franco D, Pazzagli M, Vekemans M, et
al: Isolation by size of epithelial tumor cells: A new method for
the immunomorphological and molecular characterization of
circulating tumor cells. Am J Pathol. 156:57–63. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Khoja L, Backen A, Sloane R, Menasce L,
Ryder D, Krebs M, Board R, Clack G, Hughes A, Blackhall F, et al: A
pilot study to explore circulating tumour cells in pancreatic
cancer as a novel biomarker. Br J Cancer. 106:508–516. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bobek V, Matkowski R, Gürlich R, Grabowski
K, Szelachowska J, Lischke R, Schützner J, Harustiak T, Pazdro A,
Rzechonek A and Kolostova K: Cultivation of circulating tumor cells
in esophageal cancer. Folia Histochem Cytobiol. 52:171–177. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Allard WJ, Matera J, Miller MC, Repollet
M, Connelly MC, Rao C, Tibbe AG, Uhr JW and Terstappen LW: Tumor
cells circulate in the peripheral blood of all major carcinomas but
not in healthy subjects or patients with nonmalignant diseases.
Clin Cancer Res. 10:6897–6904. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gervasoni A, Sandri MT, Nascimbeni R,
Zorzino L, Cassatella MC, Baglioni L, Panigara S, Gervasi M, Di
Lorenzo D and Parolini O: Comparison of three distinct methods for
the detection of circulating tumor cells in colorectal cancer
patients. Oncol Rep. 25:1669–1703. 2011.PubMed/NCBI
|
|
34
|
Sobin LH, Gospodarowicz MK and Wittekind
C: International Union Against Cancer: TNM Classification of
Malignant Tumours. Wiley-Blackwell. Chichester: 2010.
|
|
35
|
Vestbo J, Hurd SS, Agusti AG, Jones PW,
Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ,
Nishimura M, et al: Global strategy for the diagnosis, management,
and prevention of chronic obstructive pulmonary disease: GOLD
executive summary. Am J Respir Crit Care Med. 187:347–365. 2013.
View Article : Google Scholar : PubMed/NCBI
|
